COVID-19 and hedge fund equity ownership

被引:1
|
作者
Samarbakhsh, Laleh [1 ]
Singh, Amanjot [2 ]
机构
[1] Ryerson Univ, Ted Rogers Sch Management, Toronto, ON, Canada
[2] Univ Western Ontario, Kings Univ Coll, Sch Management Econ & Math, London, ON, Canada
关键词
COVID-19; equity ownership; hedge funds; RISK; PERFORMANCE; HOLDINGS; RETURN;
D O I
10.1111/irfi.12370
中图分类号
F8 [财政、金融];
学科分类号
0202 ;
摘要
This study investigates hedge funds equity ownership in light of the COVID-19 pandemic. Using the merged dataset of Lipper TASS hedge funds and the corresponding 13F filings, we find that with the start of the pandemic, hedge funds increased their equity ownership toward firms with less financial constraints, such as larger firms, firms with lower leverage, and more profitability. Moreover, hedge funds increased their ownership in firms which had higher overall risk (political and non-political), and lower overall sentiment. Hedge funds also care about firms' exposure/sensitivity toward different political issues such as health care, technology & infrastructure, and security & defense. This suggests that hedge funds seek equity ownership in riskier stocks as a result of pandemic uncertainties.
引用
收藏
页码:356 / 364
页数:9
相关论文
共 50 条
  • [41] COVID-19 vaccine equity and booster doses
    LANCET INFECTIOUS DISEASES, 2021, 21 (09): : 1193 - 1193
  • [42] COVID-19 vaccine equity: the need of the hour
    Ish, P.
    Talukdar, T.
    Sinha, K.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2023, 116 (01) : 85 - 85
  • [43] Health equity and COVID-19: global perspectives
    Shadmi, Efrat
    Chen, Yingyao
    Dourado, Ines
    Faran-Perach, Inbal
    Furler, John
    Hangoma, Peter
    Hanvoravongchai, Piya
    Obando, Claudia
    Petrosyan, Varduhi
    Rao, Krishna D.
    Ruano, Ana Lorena
    Shi, Leiyu
    de Souza, Luis Eugenio
    Spitzer-Shohat, Sivan
    Sturgiss, Elizabeth
    Suphanchaimat, Rapeepong
    Uribe, Manuela Villar
    Willems, Sara
    INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH, 2020, 19 (01)
  • [44] Technologies to advance COVID-19 vaccine equity
    Nature Biotechnology, 2021, 39 : 1477 - 1477
  • [45] Covid-19 and herding in global equity markets
    Rubesam, Alexandre
    Raimundo Junior, Gerson de Souza
    JOURNAL OF BEHAVIORAL AND EXPERIMENTAL FINANCE, 2022, 35
  • [46] Combating COVID-19: health equity matters
    Wang, Zhicheng
    Tang, Kun
    NATURE MEDICINE, 2020, 26 (04) : 458 - 458
  • [47] Combating COVID-19: health equity matters
    Zhicheng Wang
    Kun Tang
    Nature Medicine, 2020, 26 : 458 - 458
  • [48] Promoting health equity in the era of COVID-19
    Farley, John H.
    Hines, Jeffrey
    Lee, Nita K.
    Brooks, Sandra E.
    Nair, Navya
    Brown, Carol L.
    Doll, Kemi M.
    Sullivan, Ellen J.
    Chapman-Davis, Eloise
    GYNECOLOGIC ONCOLOGY, 2020, 158 (01) : 25 - 31
  • [49] Audio Interview: Covid-19 and Health Equity
    Rubin, Eric J.
    Baden, Lindsey R.
    Hlatshwayo Davis, Matifadza
    Morrissey, Stephen
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (23):
  • [50] Cascading failures in COVID-19 vaccine equity
    V. Lavery, James
    Porter, Rachael M.
    Addiss, David G.
    SCIENCE, 2023, 380 (6644) : 460 - 462